Related Experiment Video
Updated: Sep 20, 2025
Investigating the Effects of Probiotics on Pneumococcal Colonization Using an In Vitro Adherence Assay
Published on: April 28, 2014
Unveiling the hidden risks: analysis of adverse drug reactions associated with probiotics from the FAERS database -
Yan Jiao1, Zhi-Cheng Liu2, Ya-Hui Liu1
1Department of Hepatobiliary and Pancreatic Surgery, General Surgery Center, The First Hospital of Jilin University, Changchun, Jilin, China.
Background:
Probiotics could reduce postoperative infections and intestinal inflammation, and increase the prognostic survival rate in patients undergoing abdominal surgery. Despite its therapeutic efficacy, probiotics are also associated with some adverse drug reactions (ADRs). The FDA Adverse Event Reporting System (FAERS) database could offer several significant advantages for pharmaceutical monitoring and research. Thus, the aim of this study was to analyze the ADRs associated with probiotics using the FAERS database to guide clinical safe treatment.
Methods:
We analyzed the ADR reports related to probiotics from the FAERS database retrospectively. After removing duplicate entries, the final dataset comprised 8,150,023 records. ADRs related to probiotics were identified, and statistical analyses were conducted using the reporting odds ratio (ROR), proportional reporting ratio (PRR), Bayesian confidence propagation neural network (BCPNN), and empirical Bayesian geometric mean (EBGM).
Results:
A total of 55 ADRs induced by probiotics were found. Significant findings include high ROR and PRR values for gastrointestinal disorders, such as abdominal discomfort (ROR = 17.68, PRR = 16.87), abdominal distension (ROR = 20.88, PRR = 20.21), flatulence (ROR = 28.34, PRR = 27.68), abdominal pain upper (ROR = 7.21, PRR = 7.06), abdominal pain (ROR = 4.91, PRR = 4.84), and gastrointestinal pain (ROR = 109.48, PRR = 107.36). Uncommon disorder, including anxiety (ROR = 5.69, PRR = 5.56), agitation (ROR = 17.88, PRR = 17.55), tremor (ROR = 7.23, PRR = 7.11), suggesting very high probability of associations emerging.
Conclusion:
The analysis provides a detailed overview of the ADRs associated with probiotics, and both new and unexpected significant ADRs were identified, which enriched its safety profile. A process of continuous vigilance and additional investigations are imperative to verify these results, and to increase our knowledge on how probiotics should be handled in terms of its safety.
Insights
Probiotics may cause adverse drug reactions (ADRs), including gastrointestinal issues and anxiety. This study analyzed FAERS data to identify these risks, enhancing the understanding of probiotic safety for clinical use.
Area of Science:
- Microbiology
- Pharmacovigilance
- Gastroenterology
Background:
- Probiotics show therapeutic potential in abdominal surgery by reducing infections and inflammation.
- However, probiotics are associated with adverse drug reactions (ADRs).
- The FDA Adverse Event Reporting System (FAERS) is valuable for pharmaceutical monitoring.
Purpose of the Study:
- To analyze ADRs associated with probiotic use.
- To guide safe clinical treatment by identifying potential risks.
Main Methods:
- Retrospective analysis of probiotic-related ADR reports from the FAERS database.
- Statistical analysis using Reporting Odds Ratio (ROR), Proportional Reporting Ratio (PRR), and other methods.
- Inclusion of over 8 million records after de-duplication.
Main Results:
- Identified 55 adverse drug reactions (ADRs) linked to probiotics.
- Significant associations found for gastrointestinal disorders like abdominal discomfort, distension, flatulence, and pain.
- Noted potential associations with neurological and psychiatric effects such as anxiety, agitation, and tremor.
Conclusions:
- The study provides a comprehensive safety profile of probiotics, including novel ADRs.
- Continuous vigilance and further investigation are necessary to confirm findings.
- Enhanced understanding of probiotic safety is crucial for clinical application.
More Related Videos
Related Concept Videos
01:19Pharmacovigilance
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
01:23Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...